Se connecter

Bibliographies thématiques / Lungs Inflammation / Livres

Livres sur le sujet « Lungs Inflammation »

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Lungs Inflammation.

Auteur : Grafiati

Publié le 4 juin 2021

Mis à jour le 27 janvier 2023

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs livres pour votre recherche sur le sujet « Lungs Inflammation ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les livres sur diverses disciplines et organisez correctement votre bibliographie.

1

Symposium, on Airway Obstruction and Inflammation (1988 Florence Italy). Airway obstruction and inflammation : Present status and perspectives. Basel : Karger, 1990.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Criner, Gerard J., William D. Cornwell et Thomas J. Rogers. Smoking and lung inflammation : Basic, pre-clinical, and clinical research advances. New York : Springer, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

L, Kradin Richard, et Robinson Bruce W. S, dir. Immunopathology of lung disease. Boston : Butterworth-Heinemann, 1996.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Bertolini, Renzo. Animal and vegetable dusts as a cause of deep lung inflammation. Hamilton : CCOHS, 1988.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Michel, Chignard, et Conference on Cytokines and Adhesion Molecules in Lung Inflammation (1995 : Paris, France), dir. Cytokines and adhesion molecules in lung inflammation. New York : New York Academy of Sciences, 1996.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

F, Donner C., dir. COPD is/is not a systemic disease ? Hauppauge, NY : Nova Science, 2009.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

1952-, Strieter Robert M., Kunkel S. L et Standiford Theodore J, dir. Chemokines in the lung. New York : Marcel Dekker, Inc., 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Rogers, Thomas J., Gerard J. Criner et William D. Cornwell, dir. Smoking and Lung Inflammation. New York, NY : Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7351-0.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Dubinett, Steven M., dir. Inflammation and Lung Cancer. New York, NY : Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2724-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Alper, Scott, et William J. Janssen, dir. Lung Innate Immunity and Inflammation. New York, NY : Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8570-8.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Wang, Yong-Xiao, dir. Lung Inflammation in Health and Disease, Volume I. Cham : Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63046-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

Wang, Yong-Xiao, dir. Lung Inflammation in Health and Disease, Volume II. Cham : Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-68748-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Pokorski, Mieczyslaw. Pulmonary Infection and Inflammation. Springer London, Limited, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

14

Pokorski, Mieczyslaw. Pulmonary Infection and Inflammation. Springer, 2018.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

Pokorski, Mieczyslaw. Pulmonary Infection and Inflammation. Springer, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Dubinett, Steven M. Inflammation and Lung Cancer. Springer, 2015.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

Dubinett, Steven M. Inflammation and Lung Cancer. Springer, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Dubinett, Steven M. Inflammation and Lung Cancer. Springer, 2015.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

Rogers, Thomas J., Gerard J. Criner et William D. Cornwell. Smoking and Lung Inflammation : Basic, Pre-Clinical and Clinical Research Advances. Springer, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Martin, Thomas. Cytokines in Pulmonary Disease : Infection and Inflammation (Lung Biology in Health & Disease). Informa Healthcare, 2000.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Strieter, Robert M., Steven L. Kunkel et Theodore J. Standiford. Chemokines in the Lung. Taylor & Francis Group, 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Michel, Chignard, dir. Cells and cytokines in lung inflammation. New York, NY : New York Academy of Sciences, 1994.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

(Editor), Duncan F. Rogers, et Louise E. Donnelly (Editor), dir. Human Airway Inflammation : Sampling Techniques and Analytical Protocols (Methods in Molecular Medicine). Humana Press, 2001.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

(Editor), Trevor T. Hansel, et Peter J. Barnes (Editor), dir. Recent Advances in the Pathophysiology of COPD (Progress in Inflammation Research). Birkhäuser Basel, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

(Editor), Johan Zaagsma, Herman Meurs (Editor) et Ad F. Roffel (Editor), dir. Muscarinic Receptors in Airways Diseases (Progress in Inflammation Research). Birkhauser, 2001.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Montuschi, Paolo. New Perspectives in Monitoring Lung Inflammation : Analysis of Exhaled Breath Condensate. Taylor & Francis Group, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Montuschi, Paolo. New Perspectives in Monitoring Lung Inflammation : Analysis of Exhaled Breath Condensate. Taylor & Francis Group, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Montuschi, Paolo. New Perspectives in Monitoring Lung Inflammation : Analysis of Exhaled Breath Condensate. Taylor & Francis Group, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

New perspectives in monitoring lung inflammation : Analysis of exhaled breath condensate. Boca Raton, FL : CRC Press, 2006.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Montuschi, Paolo. New Perspectives in Monitoring Lung Inflammation : Analysis of Exhaled Breath Condensate. Taylor & Francis Group, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

31

Montuschi, Paolo. New Perspectives in Monitoring Lung Inflammation : Analysis of Exhaled Breath Condensate. Taylor & Francis Group, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Acute Lung Injury : From Inflammation to Repair (Biomedical and Health Research). Ios Pr Inc, 2001.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

33

A, Persson C. G., dir. Inflammatory indices in chronic bronchitis. Basel : Birkhäuser, 1990.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

34

1942-, Church Martin, et Robinson Clive 1958-, dir. Eicosanoids in inflammatory conditions of the lung, skin, and joints. Lancaster : MTP Press, 1988.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Ray, Abhijit, et Punit Kumar Srivastave. Obstructive Airway Diseases. Taylor & Francis Group, 2011.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Ray, Abhijit, et Punit Kumar Srivastava. Obstructive Airway Diseases : Role of Lipid Mediators. Taylor & Francis Group, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

37

Ray, Abhijit. Obstructive Airway Diseases : Role of Lipid Mediators. Taylor & Francis Group, 2011.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Ray, Abhijit, et Punit Kumar Srivastava. Obstructive Airway Diseases : Role of Lipid Mediators. Taylor & Francis Group, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Ray, Abhijit, et Punit Kumar Srivastava. Obstructive Airway Diseases : Role of Lipid Mediators. Taylor & Francis Group, 2018.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

40

Ong, Kian Chung, dir. Lung Inflammation. InTech, 2014. http://dx.doi.org/10.5772/57068.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Adlam, David. Pericardial disease. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0109.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

The pericardium forms a continuous sac around the heart, analogous to the pleura surrounding the lungs, and the peritoneum surrounding the abdominal viscera. Between the parietal and visceral layers of the serous pericardium is the pericardial space, which normally contains a small volume of pericardial fluid. The clinical spectrum of pericardial diseases can be divided into: pericarditis, caused by acute inflammation; pericardial effusion, or fluid accumulation in the pericardial space, leading to tamponade; and constrictive pericarditis, caused by chronic infiltration or inflammation leading to pericardial constriction.

42

Wick, Mark R., et Henry D. Tazelaar. Neoplastic Mimics in Thoracic and Cardiovascular Pathology. Springer Publishing Company, Incorporated, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Wick, Mark R., et Henry D. Tazelaar. Neoplastic Mimics in Thoracic and Cardiovascular Pathology. Springer Publishing Company, Incorporated, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Wiffen, Philip, Marc Mitchell, Melanie Snelling et Nicola Stoner. Therapy-related issues : musculoskeletal diseases. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199603640.003.0025.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Rheumatoid arthritis 548Gout 556Rheumatoid arthritis (RA) is an autoimmune disease which causes joints lined with synovium to become inflamed, swollen, stiff, and painful, and leads to joint erosion. It is a multisystem disorder which can affect many organs including the eyes, lungs, heart, and blood vessels. The aim of treatment is to decrease pain and inflammation, prevent joint damage, and ultimately induce remission of disease....

45

Blend, Doctor Herry. Ketoconazole : Perfect Guide for Most Effective Antifungal Treatment That Completely Cures Jock Itch, Athlete's Foot, Ringworm, Painful Inflammation, Lungs or Skin Diseases and Other Fungal Diseases. Lulu Press, Inc., 2018.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

46

Klepikov, Igor. Didactics of Acute Lung Inflammation. Cambridge Scholars Publishing, 2022.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

47

Kriemler, Susi, Thomas Radtke et Helge Hebestreit. Exercise, physical activity, and cystic fibrosis. Sous la direction de Neil Armstrong et Willem van Mechelen. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198757672.003.0027.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Cystic fibrosis (CF) is a genetic disease resulting in an impaired mucociliary clearance, chronic bacterial airway infection, and inflammation. The progressive destruction of the lungs is the main cause of morbidity and premature death. Diverse other organ systems such as heart, muscles, bones, gastro-intestinal tract, and sweat glands are often also affected and interfere with exercise capacity. Hence, exercise capacity is reduced as the disease progresses mainly due to reduced functioning of the muscles, heart, and/or lungs. Although there is still growing evidence of positive effects of exercise training in CF on exercise capacity, decline of pulmonary function, and health-related quality of life, the observed effects are encouraging and exercise should be implemented in all patient care. More research is needed to understand pathophysiological mechanisms of exercise limitations and to find optimal exercise modalities to slow down disease progression, predict long-term adherence, and improve health-related quality of life.

48

Balhara, Kamna S., Basem F. Khishfe et Jamil D. Bayram. Sepsis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0004.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Sepsis is a clinical syndrome characterized by systemic inflammation in the presence of infection. The source of infection may be occult. One must be aware of the epidemiology, presenting features and complications, diagnostic considerations and tests, and the organisms involved. Bacteria (gram positive and negative) are most commonly associated with sepsis, although fungi, viruses, and parasites can cause sepsis. Infections in the lungs, urinary tract, abdomen, skin, brain, and other areas can cause bacteremia and lead to sepsis. Treatment includes airway, breathing, and circulation (ABCs) management; aggressive fluid resuscitation; early administration of broad-spectrum antibiotics; and early goal-directed therapy and severe sepsis resuscitation bundle. Diagnosis can be challenging in pediatric and geriatric populations.

49

Lynn, William S. Inflammatory Cells & Lung Disease. Taylor & Francis Group, 2020.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

50

Kriemler, Susi. Exercise, physical activity, and cystic fibrosis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199232482.003.0033.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Résumé :

Cystic fibrosis (CF) is the most common genetic autosomal recessive disease of the Caucasian race, generally leading to death in early adulthood.1 The frequency of the gene carrier (heterozygote) is 1:20–25 in Caucasian populations, 1:2000 in African-Americans, and practically non-existent in Asian populations. The disease occurs in about 1 in every 2500 life births of the white population. Mean survival has risen from 8.4 years in 1969 to 32 years in 2000 due to improvements in treatment. The genetic defect causes a pathological electrolyte transport through the cell membranes by a defective chloride channel membrane transport protein [cystic fibrosis transmembrane conductance regulator (CFTR)]. With respect to the function, this affects mainly the exocrine glands of secretory cells, sinuses, lungs, pancreas, liver, and the reproductive tract of the human body leading to a highly viscous, water-depleted secretion. The secretion cannot leave the glands and in consequence causes local inflammation and destruction of various organs. The main symptoms include chronic inflammatory pulmonary disease with a progressive loss of lung function, exocrine and sometimes endocrine pancreas insufficiency, and an excessive salt loss through the sweat glands.1 A summary of the signs and symptoms of CF will be given with a special emphasis on the effect of exercise performance and capacity.